Sd. Skaper et al., MAST-CELL ACTIVATION CAUSES DELAYED NEURODEGENERATION IN MIXED HIPPOCAMPAL CULTURES VIA THE NITRIC-OXIDE PATHWAY, Journal of neurochemistry, 66(3), 1996, pp. 1157-1166
Mast cells are pleiotropic bone marrow-derived cells found in mucosal
and connective tissues and in close apposition to neurons, where they
play important roles in tissue inflammation and in neuroimmune interac
tions. Connective tissue mast cells, with which intracranial mast cell
s share many characteristics, contain cytokines that can cause inflamm
ation. Here, we report that myelin basic protein, a major suspected im
munogen in multiple sclerosis, as well as an antigenic stimulus, provo
kes mast cells to trigger a delayed cytotoxicity for neurons in mixed
neuron-glia cultures from hippocampus. Neurotoxicity required a prolon
ged period (12 h) of mast cell incubation, and appeared to depend larg
ely on elaboration of the free radical nitric oxide by astrocytes. Act
ivation of astrocytes was mediated, in part, by mast cell-secreted tum
or necrosis factor-alpha. Myelin basic protein and 17 beta-estradiol h
ad a synergistic action on the induction of mast cell-associated neuro
nal injury. The cognate mast cell line RBL-2H3, when subjected to an a
ntigenic stimulus, released tumor necrosis factor-alpha which, togethe
r with exogenous interleukin-1 beta (or interferon-gamma), induced ast
roglia to produce neurotoxic quantities of nitric oxide. A small but s
ignificant proportion of mast cell-derived neurotoxicity under the abo
ve conditions occurred independently of glial nitric oxide synthase in
duction. Further, palmitoylethanolamide, which has been reported to re
duce mast cell activation by a local autacoid mechanism, decreased neu
ron loss resulting from mast cell stimulation in the mixed cultures bu
t not that caused by direct cytokine induction of astrocytic nitric ox
ide synthase. These results support the notion that brain mast cells c
ould participate in the pathophysiology of chronic neurodegenerative a
nd inflammatory diseases of the nervous system, and suggest that down-
modulation of mast cell activation in such conditions could be of ther
apeutic benefit.